IV Antibiotic Regimen for Cat Bites

Indications for IV Antibiotics

• The Infectious Diseases Society of America (IDSA) recommends IV antibiotics for cat bites with established infection and systemic signs, such as fever, lymphangitis, or significant cellulitis, in patients with compromised immune systems 1
• IV antibiotics are necessary for cat bites with deep tissue involvement, including septic arthritis, osteomyelitis, or tenosynovitis, according to the IDSA guidelines 1
• The IDSA guidelines suggest that immunocompromised patients with moderate to severe cat bite injuries require IV antibiotics 2

First-Line IV Regimens

• The IDSA guidelines recommend ampicillin-sulbactam (1.5-3.0 g every 6-8 hours) as first-line therapy for cat bites requiring IV antibiotics 2
• The IDSA guidelines also recommend piperacillin-tazobactam (3.37 g every 6-8 hours) as an alternative option for cat bites requiring IV antibiotics 2
• For severe infections, the IDSA guidelines suggest using carbapenems, such as ertapenem (1 g IV daily), imipenem (1 g IV every 6-8 hours), or meropenem (1 g IV every 8 hours) 2

Critical Pitfalls to Avoid

• The IDSA guidelines advise against using first-generation cephalosporins, penicillinase-resistant penicillins, macrolides, or clindamycin monotherapy for cat bites due to poor activity against Pasteurella multocida 2

Duration of IV Therapy

• The IDSA guidelines recommend treating cellulitis or soft tissue infections for 3-5 days with IV antibiotics before transitioning to oral therapy 1
• For septic arthritis or synovitis, the IDSA guidelines suggest a total treatment duration of 3-4 weeks 1
• For osteomyelitis, the IDSA guidelines recommend a total treatment duration of 4-6 weeks 1

Transition to Oral Therapy

• The IDSA guidelines recommend transitioning to amoxicillin-clavulanate (875/125 mg twice daily) to complete the treatment course once clinical improvement occurs 2

Adjunctive Measures

• The IDSA guidelines suggest elevating the affected extremity to reduce swelling and promoting healing by secondary intention, rather than primarily closing infected wounds 2

Treatment of Cat Bites

Microbiology of Cat Bites

• Cat bites have a high infection rate and the predominant pathogens in cat bite wounds include Pasteurella multocida (found in 75% of cat bites), Staphylococci and streptococci (found in ~40% of bites), and Anaerobic bacteria (present in 65% of cat bites) 3, 4, 5
• The average cat bite wound yields 5 different bacterial isolates, with ~60% having mixed aerobic and anaerobic bacteria 4

First-Line Treatment Recommendation

• The Infectious Diseases Society of America recommends amoxicillin-clavulanate (875/125 mg twice daily) as the first-line oral therapy for cat bites due to its excellent coverage against P. multocida, good activity against staphylococci and streptococci, and effective coverage against anaerobic organisms 3, 6, 7

Why Azithromycin is NOT Preferred

• Azithromycin is not recommended for cat bite infections due to its insufficient coverage against many anaerobes commonly found in cat bites, and clinical failures have been documented with macrolides in treating P. multocida infections 3, 6, 5

Alternative Treatment Options

• For patients with penicillin allergies, the American College of Physicians recommends considering doxycycline (100 mg twice daily) or fluoroquinolones (e.g., ciprofloxacin 500-750 mg twice daily) as alternative treatment options, due to their excellent activity against P. multocida 3, 6, 7

Important Clinical Considerations

• Cat bites on the hand have the highest risk of infection and complications, and wound care including thorough irrigation and debridement is essential in addition to antibiotic therapy 4, 8
• First-generation cephalosporins, penicillinase-resistant penicillins, macrolides, and clindamycin all have poor activity against P. multocida and should be avoided 5

Potential Complications

• Infectious complications of cat bite wounds include septic arthritis and osteomyelitis (especially with hand wounds), subcutaneous abscess formation, tendonitis, bacteremia, and meningitis 4, 5

IV Antibiotic Management for Cat‑Scratch Felon after Oral Therapy Failure

First‑Line Intravenous Regimen

• The Infectious Diseases Society of America (IDSA) recommends ampicillin‑sulbactam 1.5–3 g IV every 6–8 hours as the definitive first‑line IV antibiotic for a cat‑scratch felon that has not responded to oral therapy, providing optimal coverage of the polymicrobial flora typical of cat bites. 9

Alternative Intravenous Regimens (when ampicillin‑sulbactam unavailable or contraindicated)

• Piperacillin‑tazobactam 3.37 g IV every 6–8 hours is an acceptable alternative, offering broader gram‑negative activity but lacking MRSA coverage. 9
• For patients with a penicillin allergy, carbapenems (e.g., ertapenem 1 g IV daily, meropenem 1 g IV every 8 h, imipenem 1 g IV every 6–8 h) are recommended as alternative agents. 9

Empiric MRSA Coverage

• Vancomycin 15 mg/kg IV every 12 hours should be added to any beta‑lactam‑based regimen because:
  
  • Prior failure of trimethoprim‑sulfamethoxazole (which has MRSA activity) suggests possible MRSA involvement. 10
  • Felon presentation with systemic signs warrants empiric MRSA therapy. 10
  • All beta‑lactam regimens (ampicillin‑sulbactam, piperacillin‑tazobactam, carbapenems) do not cover MRSA. 9
  • For hospitalized patients with complicated skin‑and‑soft‑tissue infection (SSTI), empiric MRSA therapy is recommended pending culture results. 10

Rationale for Switching from Oral to IV Therapy

• Trimethoprim‑sulfamethoxazole (Bactrim) provides good aerobic coverage but lacks adequate anaerobic activity, missing a critical component of cat‑bite flora. 9
• Ciprofloxacin has excellent activity against Pasteurella multocida but fails to cover MRSA and several anaerobes. 9

Transition to Oral Therapy

• After clinical improvement (reduced pain, erythema, and fever), patients may be switched to amoxicillin‑clavulanate 875/125 mg PO twice daily, which offers the same broad‑spectrum coverage as ampicillin‑sulbactam. 9

Agents to Avoid as Monotherapy for Cat‑Bite Infections

• The IDSA advises against using the following agents alone because they inadequately cover the typical polymicrobial spectrum of cat bites:
  
  • First‑generation cephalosporins (cefazolin, cephalexin) – poor P. multocida activity. 9
  • Penicillinase‑resistant penicillins (nafcillin, oxacillin) – insufficient P. multocida coverage. 9
  • Clindamycin – completely lacks P. multocida activity. 9
  • Macrolides (erythromycin, azithromycin) – poor P. multocida activity and documented clinical failures. 9

Microbiologic Evaluation

• Obtain cultures from any purulent drainage before initiating antibiotics to guide definitive therapy. 10